The epilepsy treatment is now approved as an add-on therapy for patients aged ≥ 2 years, following an appeal against NICE’s initial rejection.

Fenfluramine has been recommended by the National Institute for Health and Care Excellence for patients aged two and over ...

A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS ...

Hundreds of children in England with a rare and severe form of epilepsy are set to benefit from a new drug being rolled out ...

People with a rare form of epilepsy in England will now have a new treatment option to try following approval by NICE.

The drug is the first non-cannabinoid option for patients with LGS and an alternative to Jazz Pharma's Epidyolex (cannabidiol ...

The National Institute for Health and Care Excellence (NICE) has approved fenfluramine (Fintepla) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in people aged 2 years and ...

In a U-turn for the UK health technology assessor, the National Institute for Health and Care Excellence (NICE) has today ...

"For children and families living with Lennox-Gastaut syndrome, every day can be challenging, facing unpredictable and life-limiting seizures, and this new treatment option on the NHS will now ...

Fenfluramine has been recommended by the National Institute for Health and Care Excellence (Nice) for patients aged two and over with Lennox–Gastaut syndrome (LGS). It is the first non-cannabis ...